Home › Follicular Lymphoma › California › Baldwin Park
Pag-aaral pangklinika para sa Follicular Lymphoma sa Baldwin Park, CA
16 pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baldwin Park (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Nagre-recruitPhase 2/3
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 4 mi ang layo
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Nagre-recruitPhase 2
- Research Site, Duarte · 4 mi ang layo
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Nagre-recruitPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Duarte · 4 mi ang layo
Pag-aaral para sa Follicular Lymphoma sa ibang lungsod
- New York City, NY24 pag-aaral
- Milwaukee, WI19 pag-aaral
- Nashville, TN18 pag-aaral
- Houston, TX18 pag-aaral
- Boston, MA17 pag-aaral
- Seattle, WA15 pag-aaral
- Durham, NC15 pag-aaral
- Salt Lake City, UT13 pag-aaral
- Columbus, OH13 pag-aaral
- Chicago, IL12 pag-aaral
- San Antonio, TX12 pag-aaral
- Philadelphia, PA12 pag-aaral
Iba pang pag-aaral sa Baldwin Park
- Kanser sa Suso44 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Colorectal Cancer37 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)34 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Myelodysplastic Syndromes26 pag-aaral
- Kanser sa Ovary25 pag-aaral
- Kanser sa Baga24 pag-aaral
- Multiple Myeloma23 pag-aaral
- Kanser sa Tiyan22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.